Enhanced detection of Rift Valley fever virus using molecular assays on whole blood samples

Journal of Clinical Virology

Volumn 54, Issue 4, 2012, Pages 313-317

  Grolla, Allen ^a   Mehedi, Masfique ^b,c   Lindsay, Robbin ^a   Bosio, Catharine ^c   Duse, Adriano ^d   Feldmann, Heinz ^a,b,c  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Diagnostics; Macrophage; QRT PCR; Rift Valley fever virus; Whole blood

Indexed keywords

VIRUS RNA;

ARTICLE; BRUCELLOSIS; CHOLERA; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KENYA; LEPTOSPIROSIS; MACROPHAGE; MALARIA; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; TARGET CELL; TYPHOID FEVER; VERO CELL; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS REPLICATION; ZOONOSIS;

ANIMALS; CERCOPITHECUS AETHIOPS; HUMANS; KENYA; MACROPHAGES; PLASMA; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SERUM; VERO CELLS; VIRAL LOAD;

EID: 84863875405     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.04.022     Document Type: Article

References (22)

1. Hoogstraal H., Meegan J.M., Khalil G.M., Adham F.K. The Rift Valley fever epizootic in Egypt 1977-78. 2. Ecological and entomological studies. Trans R Soc Trop Med Hyg 1979, 73:624-629. [Translated from English].
2. Bird B.H., Khristova M.L., Rollin P.E., Ksiazek T.G., Nichol S.T. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J Virol 2007, 81:2805-2816.
3. Shoemaker T., Boulianne C., Vincent M.J., Pezzanite L., Al-Qahtani M.M., Al-Mazrou Y., et al. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-2001. Emerg Infect Dis 2002, 8:1415-1420.
4. Centers for Disease Control Prevention Rift Valley fever outbreak - Kenya November 2006-January 2007. Morb Mortal Wkly Rep 2007, 56:73-76.
5. Woods C.W., Karpati A.M., Grein T., McCarthy N., Gaturuku P., Muchiri E., et al. World Health Organization Hemorrhagic Fever Task Force, 2002. An outbreak of Rift Valley fever in northeastern Kenya, 1997-1998. Emerg Infect Dis 2002, 8:138-144.
6. Bird B.H., Bawiec D.A., Ksiazek T.G., Shoemaker T.R., Nichol S.T. Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J Clin Microbiol 2007, 45:350613.
7. Drosten C., Gottig S., Schilling S., Asper M., Panning M., Schmitz H., et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002, 40:2323-2330.
8. Smythe L.D., Smith I.L., Smith G.A., Dohnt M.F., Symonds M.L., Barnett L.J., et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect Dis 2002, 2:13.
9. Probert W.S., Schrader K.N., Khuong N.Y., Bystrom S.L., Graves M.H. Real-time multiplex PCR assay for detection of Brucella spp., B. abortus, and B. melitensis. J Clin Microbiol 2004, 42:1290-1293.
10. Lee M.A., Tan C.H., Aw L.T., Tang C.S., Singh M., Lee S.H., et al. Real-time fluorescence-based PCR for detection of malaria parasites. J Clin Microbiol 2002, 40:4343-4345.
11. Tracz D.M., Tabor H., Jerome M., Ng L.K., Gilmour M.W. Genetic determinants and polymorphisms specific for human-adapted serovars of Salmonella enterica that cause enteric fever. J Clin Microbiol 2006, 44:2007-2018.
12. Lyon W.J., TaqMan P.C.R. for detection of Vibrio cholerae O1, O139, non-O1, and non-O139 in pure cultures, raw oysters, and synthetic seawater. Appl Environ Microbiol 2001, 67:4685-4693.
13. Chase J.C., Celli J., Bosio C.M. Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect Immun 2009, 77:180-195.
14. Meegan J.M. The Rift Valley fever epizootic in Egypt 1977-1978. I. Description of the epizootic and virological studies. Trans R Soc Trop Med Hyg 1979, 73:618-623.
15. Ellis D.S., Shirodaria P.V., Fleming E., Simpson D.I.H. Morphology and development of Rift Valley fever virus in vero cell cultures. J Med Virol 1988, 24:161-174.
16. Bird B.H., Ksiazek T.G., Nichol S.T., Maclachlan N.J. Rift Valley fever virus. J Am Vet Med Assoc 2009, 234:883-893.
17. Shieh W.J., Paddock C.D., Lederman E., Rao C.Y., Gould L.H., Mohamed M., et al. Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007. Am J Trop Med Hyg 2010, 83(2 Suppl.):38-42.
18. Smith D.R., Steele K.E., Shamblin J., Honko A., Johnson J., Reed C., et al. The pathogenesis of Rift Valley fever virus in the mouse model. Virology 2010, 407:256-267.
19. McElroy A.K., Nichol S.T. Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. Virology 2012, 422:6-12.
20. Njenga M.K., Paweska J., Wanjala R., Rao C.Y., Weiner M., Omballa V., et al. Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases. J Clin Microbiol 2009, 47:1166-1171.
21. Collins C.H., Kennedy D.A. Laboratory acquired infections. Laboratory acquired infections: history, incidence causes and prevention 1999, Butterworth-Heinemann, Oxford UK, p. 1-37. 4th ed.
22. Paragas J., Endy T.P. Viral agents of human disease: biosafety concerns. Biological safety: principles and practices 2006, 179-207. ASM Press, Washington, DC. D.O. Fleming, D.L. Hunt (Eds.).